Peptides to combat viral infectious diseases
Shams Al-Azzam1, Yun Ding2, Jinsha Liu2
1Professional Scientific Services, Eurofins Lancaster Laboratories, Lancaster, PA, 17605, USA.
Peptides
|September 5, 2020
Summary
Peptides show promise for fighting viral infections like influenza and COVID-19. This review explores peptide therapies, vaccines, and diagnostics for major viral diseases.
Area of Science:
- Virology
- Immunology
- Medicinal Chemistry
Background:
- Viral infectious diseases pose a significant global health burden, causing millions of deaths.
- Existing treatments face challenges due to viral complexity and rapid mutation.
- Novel therapeutic strategies are crucial for effective viral infection control.
Purpose of the Study:
- To provide an overview of five prevalent viral infectious diseases: influenza, chronic hepatitis B, acquired immunodeficiency syndrome, severe acute respiratory syndrome, and coronavirus disease 2019.
- To explore current and potential peptide-based therapies, vaccines, and diagnostics for these diseases.
- To highlight the potential of peptides as a novel tool against viral infections.
Main Methods:
- Literature review and synthesis of existing research on viral diseases and peptide therapeutics.
- Analysis of current peptide-based interventions and their efficacy.
- Exploration of future directions for peptide applications in viral disease management.
Main Results:
- Peptides offer a promising avenue for developing new antiviral drugs and vaccines.
- Specific peptide applications are being investigated for influenza, hepatitis B, AIDS, SARS, and COVID-19.
- Peptide-based diagnostics could enhance early detection and monitoring of viral infections.
Conclusions:
- Peptides represent a versatile platform for combating viral infections due to their specificity and potential for modification.
- Continued research into peptide-based strategies is essential for addressing the ongoing threat of viral diseases.
- Peptides hold significant potential to improve treatment, prevention, and diagnostics for major global viral pathogens.
Related Concept Videos
01:29Immune Response Against Viral Pathogens
1.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
01:23Antimicrobial Proteins
12.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.7K
01:29Subviral Agents
350
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
350
00:56Viral Structure
72.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
72.9K
01:29Microorganisms in Medicine and Therapeutics
749
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
749
00:57Viral Recombination
24.6K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.6K